Ikena Oncology Inc (IKNA)
1.37
-0.04
(-2.84%)
USD |
NASDAQ |
May 08, 16:00
1.38
+0.01
(+0.73%)
After-Hours: 20:00
Ikena Oncology Total Assets (Quarterly): 192.09M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 192.09M |
| September 30, 2023 | 215.34M |
| June 30, 2023 | 171.76M |
| March 31, 2023 | 152.40M |
| December 31, 2022 | 172.26M |
| September 30, 2022 | 190.47M |
| June 30, 2022 | 211.18M |
| Date | Value |
|---|---|
| March 31, 2022 | 227.75M |
| December 31, 2021 | 247.88M |
| September 30, 2021 | 261.70M |
| June 30, 2021 | 278.83M |
| March 31, 2021 | 293.66M |
| December 31, 2020 | 168.40M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
152.40M
Minimum
Mar 2023
293.66M
Maximum
Mar 2021
214.13M
Average
211.18M
Median
Jun 2022
Total Assets (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 9.034M |
| Palatin Technologies Inc | 13.55M |
| iBio Inc | 34.02M |
| Theriva Biologics Inc | 55.22M |
| Oragenics Inc | 4.966M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 22.34M |
| Shareholders Equity (Quarterly) | 169.76M |
| Current Ratio | 12.58 |